IL1 Receptor Antagonist Controls Transcriptional Signature of Inflammation in Patients with Metastatic Breast Cancer-Reference-Cited by-同舟云学术

IL1 Receptor Antagonist Controls Transcriptional Signature of Inflammation in Patients with Metastatic Breast Cancer

Published:2018-07-16 Issue:18 Volume:78 Page:5243-5258
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Wu Te-Chia,Xu Kangling,Martinek Jan,Young Robyn R.,Banchereau Romain,George Joshy,Turner Jacob,Kim Kyung In,Zurawski Sandra,Wang Xuan,Blankenship Derek,Brookes Hannah M.,Marches Florentina,Obermoser Gerlinde,Lavecchio Elizabeth,Levin Maren K.,Bae Sookyoung,Chung Cheng-Han,Smith Jennifer L.,Cepika Alma-Martina,Oxley Kyp L.,Snipes George J.,Banchereau Jacques,Pascual Virginia,O'Shaughnessy Joyce,Palucka A. Karolina

Funder

NIH

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real‐World Incidence of Incident Noninfectious Uveitis in Patients Treated With BRAF Inhibitors: A Nationwide Clinical Cohort Study;American Journal of Ophthalmology;2024-11

2. GSDMD is associated with survival in human breast cancer but does not impact anti-tumor immunity in a mouse breast cancer model;Frontiers in Immunology;2024-08-19

3. Novel Treatments in Refractory Recurrent Pericarditis;Pharmaceuticals;2024-08-15

4. Anakinra-Loaded Sphingomyelin Nanosystems Modulate In Vitro IL-1-Dependent Pro-Tumor Inflammation in Pancreatic Cancer;International Journal of Molecular Sciences;2024-07-24

5. Targeting cytokine and chemokine signaling pathways for cancer therapy;Signal Transduction and Targeted Therapy;2024-07-22